EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY 4.0

Evaluating appetite/satiety hormones and eating behaviours as predictors of weight loss maintenance with GLP‐1RA therapy in adolescents with severe obesity

Megan O Bensignor iD, Aaron S Kelly, Alicia Kunin-Batson iD, Claudia K Fox iD, Rebecca Freese, Justin Clark, Kyle D Rudser, Eric M Bomberg iD, Justin Ryder, Amy C Gross iD

Pediatric Obesity · 2024

DOI: 10.1111/ijpo.13105 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Pediatric Obesity, 2024. Verfasst von Megan O Bensignor und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Medical School, University of Minnesota, Minneapolis, Minnesota, USA. Hauptthemen laut MEDLINE: Obesity, Morbid, Pediatric Obesity, Diabetes Mellitus, Type 2. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIDDK NIH HHS, NCATS NIH HHS, NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Whilst glucagon‐like peptide‐1 receptor agonists (GLP1‐RAs) are effective for treating adolescent obesity, weight loss maintenance (WLM; preventing weight regain) remains a challenge. Our goal was to investigate appetite/satiety hormones and eating behaviours that may predict WLM with exenatide (a GLP1‐RA) versus placebo in adolescents with severe obesity.

Methods

Adolescents who had ≥5% body mass index (BMI) reduction with meal replacement therapy were randomized to 52 weeks of once‐weekly exenatide extended release or placebo. In this secondary analysis, eating behaviours and appetite/satiety regulation hormones post‐meal replacement therapy (pre‐randomization to exenatide or placebo) were evaluated as possible predictors of WLM. Percent change in BMI from randomization to 52 weeks served as the primary measure of WLM.

Results

The analysis included 66 adolescents (mean age 16.0 years; 47% female). Lower leptin response to meal testing was associated with greater WLM in terms of BMI percent change in those receiving exenatide compared to placebo ( p = 0.007) after adjusting for sex, age and BMI. There were no other significant predictors of WLM.

Conclusions

Prior to exenatide, lower leptin response to meals was associated with improved WLM with exenatide compared to placebo. The mostly null findings of this study suggest that GLP1‐RA treatment may produce similar WLM for adolescents with obesity regardless of age, BMI, sex and eating behaviours.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Obesity, MorbidPediatric ObesityDiabetes Mellitus, Type 2AdolescentHumansFemaleMaleExenatideLeptinAppetiteWeight LossFeeding BehaviorHypoglycemic Agents

Stichwörter der Autor:innen

appetiteglucagon‐like peptide‐1 receptor agonistpediatric obesitypharmacotherapyweight regain

Substanzen

ExenatideLeptinHypoglycemic Agents

Autor:innen und Institutionen

  • Department of Pediatrics, Medical School, University of Minnesota, Minneapolis, Minnesota, USA.
  • Center for Pediatric Obesity Medicine, University of Minnesota Medical School, Minneapolis, Minnesota, USA.
  • Clinical and Translational Science Institute, Biostatistical Design and Analysis Center, University of Minnesota, Minneapolis, Minnesota, USA.
  • Division of Biostatistics and Health Data Science, University of Minnesota School of Public Health, Minneapolis, Minnesota, USA.
  • Department of Pediatrics and Surgery, Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois, USA.
  • Department of Pediatrics and Surgery, Northwestern Feinberg School of Medicine, Chicago, Illinois, USA.

ORCID-Profile: Megan O Bensignor, Alicia Kunin-Batson, Claudia K Fox, Eric M Bomberg, Amy C Gross

Förderung

  • NIDDK NIH HHS
  • NCATS NIH HHS
  • NIH HHS
  • National Institutes of Health
  • National Institute of Diabetes and Digestive and Kidney Diseases

Zitieren

APA

Bensignor, M. O., Kelly, A. S., Kunin-Batson, A., Fox, C. K., Freese, R., Clark, J., Rudser, K. D., Bomberg, E. M., Ryder, J., & Gross, A. C. (2024). Evaluating appetite/satiety hormones and eating behaviours as predictors of weight loss maintenance with GLP‐1RA therapy in adolescents with severe obesity. Pediatric Obesity. https://doi.org/10.1111/ijpo.13105

Vancouver

Bensignor MO, Kelly AS, Kunin-Batson A, Fox CK, Freese R, Clark J, et al. Evaluating appetite/satiety hormones and eating behaviours as predictors of weight loss maintenance with GLP‐1RA therapy in adolescents with severe obesity. Pediatric Obesity. 2024. doi:10.1111/ijpo.13105

BibTeX
@article{Bensignor2024,
  author = {Bensignor, Megan O and Kelly, Aaron S and Kunin-Batson, Alicia and Fox, Claudia K and Freese, Rebecca and Clark, Justin and Rudser, Kyle D and Bomberg, Eric M and Ryder, Justin and Gross, Amy C},
  title = {Evaluating appetite/satiety hormones and eating behaviours as predictors of weight loss maintenance with GLP‐1RA therapy in adolescents with severe obesity},
  journal = {Pediatric Obesity},
  year = {2024},
  doi = {10.1111/ijpo.13105}
}
Kostenlos starten →